共 299 条
- [1] Arimura A(1995)Pituitary adenylate cyclase activating polypeptide (PACAP) and its receptors: neuroendocrine and endocrine interaction Front Neuroendocrinol 16 53-88
- [2] Shioda S(2011)Evidence for a vascular factor in migraine Ann Neurol 69 635-645
- [3] Asghar MS(2014)Androgen deficiency and dry eye syndrome in the aging male Invest Ophthalmol Vis Sci 55 5046-5053
- [4] Hansen AE(1993)Passage of pituitary adenylate cyclase activating polypeptide1-27 and pituitary adenylate cyclase activating polypeptide1-38 across the blood-brain barrier J Pharmacol Exp Ther 267 690-696
- [5] Amin FM(1996)Transport of pituitary adenylate cyclase-activating polypeptide across the blood-brain barrier and the prevention of ischemia-induced death of hippocampal neurons Ann N Y Acad Sci 805 270-277
- [6] van der Geest RJ(2004)Animal models of dry eye: a critical assessment of opportunities and limitations Invest Ophthalmol Vis Sci 45 1641-1646
- [7] Koning P(2007)The effect of intravenous PACAP38 on cerebral hemodynamics in healthy volunteers Regul Pept 140 185-191
- [8] Larsson HBW(2005)Computer vision syndrome: a review Surv Ophthalmol 50 253-262
- [9] Olesen J(2009)The in vivo effect of VIP, PACAP-38 and PACAP-27 and mRNA expression of their receptors in rat middle meningeal artery Cephalalgia 29 837-847
- [10] Ashina M(2005)Pituitary adenylate cyclase-activating polypeptide (PACAP) can act as determinant of the tyrosine hydroxylase phenotype of dopaminergic cells during retina development Brain Res Dev Brain Res 156 193-201